Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Visser

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2024
Does "One Size Fits All"? Rethinking FIGO Depth of Invasion Measurements in Vulvar CancerMaaike C G Bleeker, Tjalling Bosse, Koen K van de Vijver, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 17, 2016
Long-term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsyNicole C M Visser, Ellen M Sparidaens, Jan-Willem van den Brink, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 5, 2017
Type of vascular invasion in association with progress of endometrial cancerNicole C M Visser, Henrica M J Werner, Camilla Krakstad, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|January 8, 2024
Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?Stephanie W Vrede, Hannah Donkers, Casper Reijnen, et al.
Human Pathology|December 18, 2020
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration studyWillem Jan van Weelden, Casper Reijnen, Heidi V N Küsters-Vandevelde, et al.
JAMA Network Open|December 16, 2022
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial CancerStephanie W Vrede, Jenneke Kasius, Johan Bulten, et al.
BMC Cancer|July 1, 2015
PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort studyNicole C M Visser, Johan Bulten, Anneke A M van der Wurff, et al.
Human Pathology|August 21, 2021
Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panelNicole C M Visser, Anneke A M van der Wurff, Joanna IntHout, et al.
Gynecologic Oncology|April 16, 2021
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancerS W Vrede, W J van Weelden, N C M Visser, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2025
Surgical stage in the era of molecular profiling of endometrial cancerJ C Kasius, W Kildal, S W Vrede, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2024
Does "One Size Fits All"? Rethinking FIGO Depth of Invasion Measurements in Vulvar CancerMaaike C G Bleeker, Tjalling Bosse, Koen K van de Vijver, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 17, 2016
Long-term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsyNicole C M Visser, Ellen M Sparidaens, Jan-Willem van den Brink, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 5, 2017
Type of vascular invasion in association with progress of endometrial cancerNicole C M Visser, Henrica M J Werner, Camilla Krakstad, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|January 8, 2024
Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?Stephanie W Vrede, Hannah Donkers, Casper Reijnen, et al.
Human Pathology|December 18, 2020
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration studyWillem Jan van Weelden, Casper Reijnen, Heidi V N Küsters-Vandevelde, et al.
JAMA Network Open|December 16, 2022
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial CancerStephanie W Vrede, Jenneke Kasius, Johan Bulten, et al.
BMC Cancer|July 1, 2015
PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort studyNicole C M Visser, Johan Bulten, Anneke A M van der Wurff, et al.
Human Pathology|August 21, 2021
Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panelNicole C M Visser, Anneke A M van der Wurff, Joanna IntHout, et al.
Gynecologic Oncology|April 16, 2021
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancerS W Vrede, W J van Weelden, N C M Visser, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2025
Surgical stage in the era of molecular profiling of endometrial cancerJ C Kasius, W Kildal, S W Vrede, et al.
Pageof 4